MedTrace Logo

Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients

NCT02465424 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2018-05-22

No results posted yet for this study

Summary

The purpose of this study is to determine which Health Related Quality of Life (HRQoL) tools patients with medullary thyroid cancer (MTC) find most helpful. The study will compare a generic cancer QoL tool with those developed for thyroid cancer patients and neuroendocrine tumour (NET) patients. The study will also evaluate clinicians' opinions on the clinical usefulness of the QoL tools.

Conditions

Interventions

OTHER

quality of life questionnaires

Randomised allocation of 4 validated quality of life questionnaires followed by study specific overview questionnaire

Sponsors & Collaborators

  • Velindre NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Laura Moss, MB BCh · Velindre NHS Trust

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02465424 on ClinicalTrials.gov